Sale of Sentenial Group and its open banking brand Nuapay
The shareholders of Sentenial Group have sold the business and its open banking brand Nuapay, a leading end-to-end payments platform specialized in account-2-account transactions, to EML Payments.
Through its regulated subsidiary Nuapay, Sentenial operates in the fast-growing European open banking sector. The group powers a complete set of payments for credit transfers, direct debits, instant payments and open banking. Over US$50 billion worth of transactions are processed annually across 37 countries. Under the Sentenial brand, the group’s original SaaS business model provides white-label use of its payment processing technology to banks and corporates. Nuapay combines Sentenial’s bank-grade payments platform with regulated services in a next-generation alternative payments and open banking solution.
EML Payments is an Australian-listed payments technology company. EML provides an innovative global payment solutions platform, with years of experience in banking, credit, and disbursement services, earned wage access, gifts, incentives and rewards, open banking and FX solutions. With open banking set to fundamentally change the way we move money over the next decade, the EM – Nuapay product proposition combines open banking data enrichment with instant account payment capability to create a modern friction-free digital user experience.
Oaklins Cavendish, based in the UK, advised the shareholders of Sentenial on the sale of the business to EMP Payments.



Tom Cregan
CEO, EML Payments
Talk to the deal team
Paris McNicol-Outch
Oaklins Cavendish
Related deals
Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Learn moredoValue has finalized a rights issue
doValue has successfully completed a rights issue. The capital increase was implemented to finance doValue’s acquisition of Gardant.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more